Prolacta's role in advancing neonatal nutrition

- 1922 – First premature infant-focused hospital unit opens in US
- 1940s – Cow milk-based feedings are the protocol of choice
- 1980s – Commercial human milk (cow milk-based) fortifiers introduced for preterm infants in the NICU
- 1999 – Prolacta founded to advance the science of human milk and address the complications of prematurity
- 2009 – Clinical trial showed that Prolacta human milk-based fortifiers reduced the incidence of NEC by 77%, compared to cow milk-based fortifiers
- 2014-2020 – More than twenty peer-reviewed clinical studies compare outcomes of Prolacta's fortifiers to cow milk-based products
- 2021 – Prolacta explores therapeutic potential of human milk, including applications for critically ill infants